ALLISON HARBILAS: Open Payments
NPI 1568023240 · OCALA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,058 in 47 payments from 11 companies in 2025. Trend: 2023 $1,557 · 2024 $1,330 · 2025 $1,058
Food & beverage: $1,058
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $213 |
| Janssen Biotech, Inc. | 10 | $179 |
| Botanix SB Inc | 3 | $162 |
| Regeneron Healthcare Solutions, Inc. | 4 | $103 |
| Amgen Inc. | 3 | $84 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $74 |
| Novartis Pharmaceuticals Corporation | 3 | $74 |
| Lilly USA, LLC | 2 | $57 |
| LEO Pharma Inc. | 2 | $52 |
| Galderma Laboratories, L.P. | 2 | $50 |
Products named: TREMFYA, SOFDRA, RINVOQ, DUPIXENT, SKYRIZI, OTEZLA, ILUMYA, COSENTYX.
Industry payments across FL — which companies pay providers there.
